ESP in Breast Surgery Due to Cancer

• Status: Completed
• Trial end date: 2021-08-17
• Target enrollment: 0
• Participant gender: Female

Summary

Patients scheduled for breast surgery due to cancer. Each patient will be treated with intravenous (i.v.) oxycodone - patient-controlled analgesia (PCA). Patients will be allocated to one of three groups: erector spinae plane (ESP) block, sham block, controlled group.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Lublin
• Treatments: Acetaminophen; Oxycodone

Criteria

Inclusion Criteria:

• Elective surgery of breast due to cancer

• obtained consent

Exclusion Criteria:

• the lack of consent

• the surgery of two breasts

• reoperation of the same breast

• previous participation in the study

• coagulopathy

• allergy to morphine and local anesthetics

• depression, antidepressant drugs treatment

• epilepsy

• usage of painkiller before surgery

• addiction to alcohol or recreational drugs